Neuron BioPharma owns two patented vegetable compounds that reduce oxidative stress, neuronal and oligodendrial death in cellular and animal models of neurodegenerative disease. Because of this fact, these compounds present a high rate of applicability with therapeutical and prophylactic purposes in risk population. Due to their very low toxicity profile, their uses as nutraceuticals is highly recommendable and do not require any complex clinical trial, as do conventional drugs.
|